The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALKERMES PLC COM G01767105   25,466 918,038 SH   SOLE   918,038 0 0
BIOGEN INC COM 09062X103   41,527 160,480 SH   SOLE   160,480 0 0
CARDINAL HEALTH INC COM 14149Y108   28,373 281,476 SH   SOLE   281,476 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106   6,990 742,824 SH   SOLE   742,824 0 0
EXELIXIS INC COM 30161Q104   45,559 1,899,079 SH   SOLE   1,899,079 0 0
JAZZ PHARMACEUTICALS PLC COM G50871105   12,300 100,000 SH   SOLE   100,000 0 0
MASIMO CORP COM 574795100   938 8,000 SH   SOLE   8,000 0 0
MURAL ONCOLOGY PLC COM G63365103   538 90,833 SH   SOLE   90,833 0 0
REGENERON PHARMACEUTICALS COM 75886F107   41,504 47,256 SH   SOLE   47,256 0 0
SANOFI-ADR COM 80105N105   7,479 150,400 SH   SOLE   150,400 0 0
TARO PHARMACEUTICAL INDUS COM M8737E108   27,009 646,453 SH   SOLE   646,453 0 0
UNITED THERAPEUTICS CORP COM 91307C102   44,170 200,872 SH   SOLE   200,872 0 0